New paper in the ASM journal AAC

MicroPath co-published a paper entitled "In vitro activity of combination formulations of the novel metallo-β-lactamase (MBL) inhibitor APC148 with comparator treatments against 176 MBL-containing Enterobacterales isolates from the SENTRY Antimicrobial Surveillance Program (2019-2022)" in the American Society of Microbiology journal Antimicrobial Agents and Chemotherapy. This is a follow up story of the antimicrobial adjuvant APC148 invented by the biotech company Adjutec Pharma AS with whom we have had a long time collaboration. 

The paper can be viewed: https://www.semanticscholar.org/paper/In-vitro-activity-of-combination-formulations-of-Smith-Klem/e7252792d7ed1c052b6c391d1afa2600a6883e7d